51 results about "Laboratory Test Result" patented technology

A system provides comprehensive patient and resource status information (manpower and equipment required to maintain optimal patient care) in an organization (e.g., a hospital) for use in adjusting resources to meet existing and future conditions. A system for monitoring activity in a healthcare enterprise includes an acquisition interface for acquiring acuity data representative of severity of medical condition of an individual patient, for multiple different patients. A monitoring processor monitors data identifying orders initiated for treatment to be provided to an individual patient and data identifying laboratory test results received for an individual patient, for multiple different patients. A data processor generates data representing status of healthcare activity for multiple patients in response to the data identifying orders and laboratory test results and the acuity data, for multiple different patients. An interface processor provides the data representing status of healthcare activity to a healthcare worker.

A system identifies multiple medical conditions, observations, and laboratory test results using active sensors and predetermined rules to identify infected patients. An infection control and workflow management system includes a repository of worker information identifying healthcare workers for performing infection control tasks as well as worker associated communication data for use in informing healthcare workers of infection control tasks to be performed. A detection processor automatically detects infection in patients from multiple different sources including from at least one of, (a) a medical record evaluated upon admission of a patient to a hospital and (b) a laboratory test result. A workflow processor uses the worker information for automatically communicating a message to inform a healthcare worker of a task to be performed to initiate infection control tasks using communication data in response to detection of an infected patient.

A system is provided that integrates of records of clinical laboratory services into the assessment and optimization of patient health care and, in particular, regulation of the use of pharmaceuticals. Laboratory test result records are used in conjunction with other health care benefits records to monitor regulation of use of pharmaceuticals by patients. The incorporation of laboratory tests and results into such a utilization system allows improvement in the management of a patient's therapy based on a more precise picture of the patient's level of illness as revealed by the laboratory test results. The system of the present invention also allows optimization of the selection of laboratory tests to be performed, and also provides an outcome assessment of the risk of hospitalization due to pharmaceutical treatments resulting in physician intervention, leading to a change in physician prescribing behavior and, accordingly, a decrease in drug induced hospitalizations and improved quality of patient care and savings of health care costs.

A method and computer program collects patients' medical information and presents the information to a user via an interactive user interface (400) that includes a plurality of information tabs. Each tab presents information about a particular patient from a certain phase of the patient's visit to a healthcare providing facility. The information tabes include diagnoses (402), heart lab (404), radiology (406), pre-operative (408), operative (410), post-operative (412), reports (414), discharge (416), and follow up (418). The post-operative tab presents laboratory test results in the form of a table (514) and a chart (516), wherein the chart includes laboratory test results graphed over time and corresponding event and normal value indicators.

A medical risk assessment method and computer program product resident on a computer or a hand-held device that allows a physician to determine the best strategy for primary and secondary cardiovascular disease prevention utilizing current guidelines and published medical literature. The computer program product evaluates a number of risk factors to determine specific recommendations for an individual patient, including Framingham risk scoring (FRS), pertinent medical history, individual lipid panel and advanced lipoprotein profiling, patient laboratory test results, and published literature on the effects of anti-lipid medicines on plasma concentration and / or composition of lipoprotein molecules and clinical outcomes. The risk assessment method establishes a cardiovascular treatment therapy strategy for a patient by determining a cardiac risk classification group, determining a cardiovascular treatment therapy based on the patient's lipoprotein profile and the patient's cardiac group risk classification, and presenting the cardiovascular treatment therapy for the patient to a medical practitioner on a patient evaluation display.

A method and computer program manages medical research study information and laboratory test result information. The program generates an interactive user interface with elements for setting up a study (702), managing study member information (704), managing patient information (706), receiving and displaying comments (708), and configuring data to be stored in a database associated with the research study (710). The program also receives medical event information from a user and laboratory test result information from a laboratory information system (20d), and generates a chart (934) that correlates the test results and the medical events. The program also receives a normal range pertaining to a test result from the laboratory information system (20d) and provides a normal range indicator (952) for the test result.

A system is provided that integrates of records of clinical laboratory services into the assessment and optimization of patient health care and, in particular, regulation of the use of pharmaceuticals. Laboratory test result records are used in conjunction with other health care benefits records to monitor regulation of use of pharmaceuticals by patients. The incorporation of laboratory tests and results into such a utilization system allows improvement in the management of a patient's therapy based on a more precise picture of the patient's level of illness as revealed by the laboratory test results. The system of the present invention also allows optimization of the selection of laboratory tests to be performed, and also provides an outcome assessment of the risk of hospitalization due to pharmaceutical treatments resulting in physician intervention, leading to a change in physician prescribing behavior and, accordingly, a decrease in drug induced hospitalizations and improved quality of patient care and savings of health care costs.

A medical diagnosis decision support system for assisting a health professional to diagnose a medical condition. The system is first provided with an anchor condition that can be a symptom, a sign, a laboratory test result, or an imaging test results or any combination thereof The system then guides users in a series of predetermined phases regarding abstract or concrete diagnosis groups that should be considered and appropriate data that should be collected during the clinical investigation process. The system suggests history and physical examination clinical data items, laboratory, and imaging tests that should be collected in order to differentiate among alternative diagnoses. In each phase, possible diagnoses are listed and ranked.

A method and computer program manages medical research study information and laboratory test result information. The program generates an interactive user interface with elements for setting up a study (702), managing study member information (704), managing patient information (706), receiving and displaying comments (708), and configuring data to be stored in a database associated with the research study (710). The program also receives medical event information from a user and laboratory test result information from a laboratory information system (20d), and generates a chart (934) that correlates the test results and the medical events. The program also receives a normal range pertaining to a test result from the laboratory information system (20d) and provides a normal range indicator (952) for the test result.

A system and method are provided that addresses the need for an improved microbiology validation system that monitors and validates clinical culture laboratory test results as they occur throughout the testing lifecycle of a clinical culture. Techniques are provided that consider the results of earlier performed tests when entering results for later performed tests so that inconsistent or wrong test results of a patient are not inadvertently released to a physician for review.

A system identifies multiple medical conditions, observations, and laboratory test results using active sensors and predetermined rules to identify infected patients. An infection control and workflow management system includes a repository of worker information identifying healthcare workers for performing infection control tasks as well as worker associated communication data for use in informing healthcare workers of infection control tasks to be performed. A detection processor automatically detects infection in patients from multiple different sources including from at least one of, (a) a medical record evaluated upon admission of a patient to a hospital and (b) a laboratory test result. A workflow processor uses the worker information for automatically communicating a message to inform a healthcare worker of a task to be performed to initiate infection control tasks using communication data in response to detection of an infected patient.

A system uses clinical data to help identify incorrect demographic information (such as gender or age) of a patient that may cause an erroneous critical or abnormal indication in medical tests and uses results of a clinical test to indicate possible demographic errors and various methods to modify a workflow to incorporate alternative tasks or to request verification of specific demographic facts. A system for validating patient medical information includes an input processor for receiving a laboratory test result value of a particular patient. A data processor automatically compares the received laboratory test result value with a predetermined normal value range for a patient having demographic characteristics of the particular patient, and compares the received laboratory test result value with a predetermined normal value range for a patient having different demographic characteristics than the particular patient. A communication processor initiates generation of an indication to a user indicating stored demographic information of the particular patient may be inaccurate.

A system uses clinical data to help identify incorrect demographic information (such as gender or age) of a patient that may cause an erroneous critical or abnormal indication in medical tests and uses results of a clinical test to indicate possible demographic errors and various methods to modify a workflow to incorporate alternative tasks or to request verification of specific demographic facts. A system for validating patient medical information includes an input processor for receiving a laboratory test result value of a particular patient. A data processor automatically compares the received laboratory test result value with a predetermined normal value range for a patient having demographic characteristics of the particular patient, and compares the received laboratory test result value with a predetermined normal value range for a patient having different demographic characteristics than the particular patient. A communication processor initiates generation of an indication to a user indicating stored demographic information of the particular patient may be inaccurate.

An integrated point of care medication administration system comprises a point of care medication administration system including an interface for communicating with the at least one repository and information sources and including a processor. The processor uses the information and the interface in automatically acquiring for a particular patient, data representing particular patient parameters and laboratory test results associated with a particular individual medication in response to user initiation of an order for the particular individual medication to be administered to the particular patient. A display device presents at least one display image indicating acquired particular patient parameters and laboratory test results of the particular patient and identifying a particular patient parameter or laboratory test result needing to be acquired prior to administration of the particular individual medication to the particular patient.

The invention provides a system and method of collecting, storing and managing laboratory test results of patients. In one embodiment the invention is directed towards collecting, storing and managing laboratory test results of patients taking an endothelin receptor antagonist (ERA). The system provides a way of securely collecting and tracking information from a plurality of patients, a plurality of laboratories, and a plurality of health care providers by use of a database. The method comprises receiving patient information from health care providers, receiving a laboratory test schedule for each patient, and laboratory tests needed for each patient. This data is entered into a central processing computer. The patients then go to any laboratory to have the monthly testing done due to the ERA prescription. The laboratory test data collected is sent to the central processing computer. The central processing computer can generate an automated report on the laboratory results and supply the results to the health care provider. Additionally, if no laboratory test data for the patient is entered into the central processing computer in accordance with the laboratory test schedule for the patient, the central processing computer will notify a call center which will call the patient, laboratory or health care provider informing them of the overdue laboratory test data.

A computerized system and method that automates diagnosing and prescribing treatment plans for patients with medical conditions, such as: dermatological (e.g. acne, dark spots, anti-aging), high blood pressure, diabetes, pre and post-surgical care, pain management, simple infections, and other medical conditions with standardized treatment protocols. The user inputs data comprising symptoms on their mobile device or a kiosk, e.g. a digital photograph of the user's body and / or face made with the computer's camera. The data is analyzed locally or on a remoter server, and an email is returned comprising the diagnosis and treatment plan. If a doctor's approval is required, the server will electronically communicate with a doctor's office computer, and receive the approval, to include authorization for a medical-drug prescription. User medical data input further comprises medical diagnostic equipment and / or laboratory test results that are transmitted to the user's mobile device, kiosk, or directly to the remote server.

The invention provides an optimized automation-adaptable platelet aggregation function inspection and analysis method, and belongs to the field of clinical laboratory medicine. The method is an improvement and optimization of a platelet aggregation function inspection and analysis method using an automation counting method. The method is suitable for platelet aggregation function automatic analysis instruments using the counting method. According to the method, the number of platelets is inspected and recorded and an aggregation rate is calculated. A laboratory test result shows that the method is better in repeatability of the obtained result of platelet aggregation rate compared with a previous largest aggregation rate method.

The present invention relates to a method of holding laboratory test results in a computerized environment. The method receives a laboratory test result for a healthcare order for a patient. The healthcare order comprises multiple laboratory tests. The method determines whether all of the test results for the healthcare order have been received. If all of the test results for the healthcare order have not been received, the laboratory test result is held until all of the results for the healthcare order have been received. If all of the results for the healthcare order have been received, the method compares each test result of the healthcare order to predefined criteria to determine whether each test result for the healthcare order is within a predetermined acceptable range. If each of the test results for the healthcare order is within the acceptable range, the entire order is automatically verified.

The present invention discloses an alkali corrosion resistance high strength steel and a production method thereof, wherein the steel comprises, by mass, 0.15-0.20% of C, 0.45-0.75% of Si, 0.75-1.35% of Mn, less than or equal to 0.015% of P, less than or equal to 0.015% of S, 0.2-0.3% of Cu, 0.1-0.25% of Ni, 0.01-0.03% of Ti, 0.8-1.3% of Cr, 0.001-0.003% of B, 0.08-0.12% of V, 0.008-0.0120% of N, and the balance of Fe and unavoidable impurities. Compared with the existing ordinary building steel, the steel of the present invention has the following characteristic that the corrosion resistance in the alkaline environment is significantly improved, wherein laboratory test results show that the corrosion resistance is more than 2 times the corrosion resistance of the ordinary reinforcing steel bar. Compared with the epoxy resin coating reinforcing steel bar, the steel of the present invention has the excellent corrosion resistance, wherein the peeling phenomenon is easily generated on the epoxy resin coating reinforcing steel bar surface and the corrosion rate is high after the peeling. Compared with the stainless steel, the steel of the present invention has the substantially reduced production cost.

The present invention relates to a method of holding laboratory test results in a computerized environment. A first laboratory test result is received, and is related to one or more other laboratory tests that comprise a healthcare order. It is determined whether the test results of the order have been received. If they have all been received, the test results are compared to predefined criteria and are determined to be considered normal. Once determined to be considered normal, the order is automatically verified. If the tests results of the healthcare order have not all been received, the first laboratory test result is held until all of the test results have been received.

A system and method are provided that addresses the need for an improved microbiology validation system that monitors and validates clinical culture laboratory test results as they occur throughout the testing lifecycle of a clinical culture. Techniques are provided that consider the results of earlier performed tests when entering results for later performed tests so that inconsistent or wrong test results of a patient are not inadvertently released to a physician for review.

The present invention relates to a method and system for suspending the processing of laboratory test results in a computerized environment. One or more test results from an instrument in a healthcare laboratory are received. It is determined whether the instrument has had a quality control procedure performed within a predefined period. If not, the processing of the one or more test results is suspended until the quality control procedure has been performed on the instrument. If the quality control procedure has been performed within the predefined period, it is determined whether the quality control procedure performed indicates that the instrument is performing properly. If not, the processing of the one or more test results is suspended until the quality control issue is resolved.

The invention provides a system and method of collecting, storing and managing laboratory test results of patients. In one embodiment the invention is directed towards collecting, storing and managing laboratory test results of patients taking an endothelin receptor antagonist (ERA). The system provides a way of securely collecting and tracking information from a plurality of patients, a plurality of laboratories, and a plurality of health care providers by use of a database. The method comprises receiving patient information from health care providers, receiving a laboratory test schedule for each patient, and laboratory tests needed for each patient. This data is entered into a central processing computer. The patients then go to any laboratory to have the monthly testing done due to the ERA prescription. The laboratory test data collected is sent to the central processing computer. The central processing computer can generate an automated report on the laboratory results and supply the results to the health care provider. Additionally, if no laboratory test data for the patient is entered into the central processing computer in accordance with the laboratory test schedule for the patient, the central processing computer will notify a call center which will call the patient, laboratory or health care provider informing them of the overdue laboratory test data.

The invention relates to the technical field of testing devices, in particular to a full-size photovoltaic module IAM testing device and a testing method thereof.The full-size photovoltaic module IAM testing device is provided with a transverse rod, rotating shafts are symmetrically and vertically arranged at the positions, opposite to the ground, of the lower end of the transverse rod, and a bearing penetrates through the joint of one end of each rotating shaft and the transverse rod; the other end of the rotating shaft is fixed on a support, and a photovoltaic assembly is fixed on the support. According to the full-size photovoltaic module IAM test device and the test method thereof, the power generation performance of the full-size photovoltaic module at different angles can be measured, so that a laboratory test result is closer to the actual power generation efficiency of a photovoltaic power station; the power generation efficiency of the photovoltaic module is guaranteed, and the income of the whole photovoltaic power station is improved.

The invention provides a method for discriminating hydrophobic migration characteristics of silicone rubber based on different salt components. The method comprises the following steps: respectively preparing soiling solutions with the salt components of NaCl, CaCl2 and (NH4)2SO4 and an ash component of diatomite; testing the hydrophobicity of samples treated by the soiling solutions with different salt components at different migration times, wherein the testing time is 24h, 48h, 96h and 144h after migration respectively; determining a saturation value of a hydrophobic migration angle, calculating indexes of the hydrophobic migration characteristics according to hydrophobic migration testing results, and discriminating the hydrophobic migration characteristics. By the method, the seven indexes of the hydrophobic migration characteristics are creativity used for comprehensively evaluating the characteristics of the silicone rubber; by the method, through a simulation test based on a variety of soiling solutions, the hydrophobic migration characteristics of the silicone rubber are comprehensively evaluated, so that laboratory test results are more closely related to field application.

Lab tests may be processed for a user through execution of a lab test coaching engine stored in memory and executable by a processor. The lab test coaching engine accesses user lab test results and processes the user lab test results based on a coaching protocol and user health data. The results of the lab test results are reported to the user and a health care professional and the lab test coaching engine may perform an action based processed lab test results.

This invention provides a fluid sample retrieval kit, including a sample transfer tube, to facilitate a method of confidentially providing laboratory test results to a consumer of the fluid sample retrieval kit. Additionally, this invention provides a method to compare clinical chemistry values from a plurality of consumers for a designated nutritional supplement, or a combination of nutritional supplements. Additionally, this method provides a fluid sample retrieval system.

The invention provides a method for inducing DC-CIK by utilizing muramyl dipeptide, that is to say, the muramyl dipeptide is added into a CIK or DC-CIK culture solution to induce proliferation and differentiation of CIK or DC-CIK cells, so as to improve the tumor-killing activity of the CIK or DC-CIK cells. The method comprises the following steps: peripheral blood collection, tumor antigen acquisition, mononuclear cell separation, mononuclear cell collection, mononuclear cell washing, MDP-DC-CIK cell induction, and culture. MDP-DC-CIK cells introduced and cultured by the method are detected by a flow cytometry, the ratio of CD3+CD56+ non-MHC restricted NKT cells is found to be up to 80% or more; and at the same time, the activity of tumor killer cells is much higher than that of DC-CIK cells by conventional induction culture, and a laboratory test result of the tumor-killing percentage reaches 99% or more.

The invention relates to a filter collector for pituitary tumor surgical specimens. The filter collector for pituitary tumor surgical specimens comprises a suction tube (2) and a negative pressure suction tube (3). One end of the suction tube (2) is provided with a suction hose (4) used to suck specimen tissues. The other end of the suction tube (2) is provided with a connector. The connector is connected with a filter tube (1). A filter (5) is arranged inside the filter tube (1). The other end of the filer tube (1) matches with a connection of the negative pressure suction tube (3) in shape and is disposed on the connection of the negative pressure suction tube (3). The filter collector enables collection of tumor specimens for brain tumor surgery to be convenient collection to be faster, and acquisition of large specimen tissues to be easy, so that accuracy in laboratory test results is increased and related fundamental research is facilitated.